-
Mashup Score: 124Pharmacological and Clinical Appraisal of Factor XI Inhibitor Drugs - 3 month(s) ago
Abstract. The evolution of anticoagulation therapy, from vitamin K antagonists to the advent of direct oral anticoagulants (DOACs) almost two decades ago, marks
Source: academic.oup.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1
AbstractAims. Subcutaneous (SC) furosemide has potential advantages over intravenous (IV) furosemide by enabling self-administration or administration by a lay
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
A novel subcutaneous formulation of #furosemide delivered by an abdominal patch infusion device in patients with #HF: data from two phase 1 studies https://t.co/QVkO7S0B7O @AgewallStefan @FeliceGragnano @escardio #EHJPharmacotherapy #ESCYoung https://t.co/MQWZNS4Xpg
-
-
Mashup Score: 0
AbstractAims. The clinical relevance of common pharmacokinetic interactions with non-vitamin K antagonist oral anticoagulants (NOACs) often remains unclear. The
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Impact of P-gp and CYP3A4-interacting drugs on clinical outcomes in patients with #AFib using #NOACs: a nationwide cohort study https://t.co/Q2um9RnC4f @AgewallStefan @FeliceGragnano @GrymonprezMaxim @LiesLahousse #EHJPharmacotherapy #ESCYoung https://t.co/8m0LmQl4zA
-
-
Mashup Score: 0Predictive value of the thrombotic risk criteria proposed in the 2023 ESC guidelines for the management of ACS: insights from a large PCI registry - 7 month(s) ago
AbstractAim. To assess the value of the thrombotic risk criteria proposed in the 2023 guidelines of the European Society of Cardiology (ESC) for the management
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Predictive value of the thrombotic risk criteria proposed in the 2023 ESC guidelines for the management of ACS: data from a large PCI registry https://t.co/p6UQiwmjLV @AlessSpirito @Drroxmehran @Mountsinaiheart @AgewallStefan @FeliceGragnano #EHJPharmacotherapy #ESCYoung https://t.co/tl4ABiDPbR
-
-
Mashup Score: 0What's new in pharmacotherapy at ESC Congress 2023? - 7 month(s) ago
This year, the European Society of Cardiology (ESC) Congress in Amsterdam featured 9 Hot Line sessions on some of the most anticipated and potentially practice-
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
What’s new in pharmacotherapy at #ESCCongress 2023? https://t.co/2blx3SPico @AgewallStefan @FeliceGragnano @paolocalabro1 @MattiaGalli10 #EHJPharmacotherapy #ESCYoung https://t.co/A3yf6iqJAE
-
-
Mashup Score: 0
AbstractBackground. Guidelines recommend extended dual antiplatelet therapy (DAPT), including ticagrelor 60 mg twice daily, in high-risk post myocardial infarct
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Clinical outcomes in patients with prior #MI treated with extended #DAPT with #ticagrelor 60 mg: data from the multinational ALETHEIA study https://t.co/Vlx2TxIwsZ @MarcBonaca @AgewallStefan @FeliceGragnano #EHJPharmacotherapy https://t.co/4TLQl6tEab
-
-
Mashup Score: 0External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis - 7 month(s) ago
AbstractAims. To summarise the totality of evidence validating the Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Du
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
External validity of PRECISE-DAPT score in patients undergoing #PCI: a meta-analysis of 21 studies and >67K patients 🩸 https://t.co/aBSvNLfw2Q @Costa_F_8 @vlgmrc @AgewallStefan @FeliceGragnano #EHJPharmacotherapy #ESCYoung https://t.co/Wf2Huct7K7
-
-
Mashup Score: 1Most Read Articles - 8 month(s) ago
See what your peers are reading! The European Heart Journal – Cardiovascular Pharmacotherapy editors invite you to read the top 20 most read articles published
Source: academic.oup.comCategories: General Medicine News, Latest HeadlinesTweet-
Making the most of #ESCCongress 2023 day 4 by attending the #EHJPharmacotherapy editorial board meeting, led by @AgewallStefan. Take a look at the Journal’s most popular recently published articles ➡️ https://t.co/aCbmZ5OBA8 https://t.co/gan9uWQFG1
-
-
Mashup Score: 0Platelet activation and endothelial dysfunction biomarkers in acute coronary syndrome: the impact of PCSK9 inhibition - 8 month(s) ago
AbstractAims. Platelet activation and endothelial dysfunction contribute to adverse outcomes in patients with acute coronary syndromes (ACS). The goals of this
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
PCSK9-I to reduce platelet activation and endothelial dysfunction in the early post-infarction period: a biomarker study 🔥 https://t.co/s3PotZupc6 @TZiogos @TLeucker @AgewallStefan @FeliceGragnano #EHJPharmacotherapy #ESCYoung https://t.co/2eFlcbO3Fz
-
-
Mashup Score: 27The Effect of SGLT2 Inhibitors on the Endothelium and the Microcirculation: From Bench to Bedside and Beyond - 9 month(s) ago
Abstract. The beneficial cardiovascular effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors irrespective of the presence of diabetes mellitus are nowad
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Evidence suggests a beneficial effect of #SGLT2i on endothelial function, but their effect on microcirculation is conflicting: a new review article by @KyriakosDimitr1 et al. covers this evolving area https://t.co/97u28m4phW @AgewallStefan @FeliceGragnano #EHJPharmacotherapy… https://t.co/NXGiMGJQY3 https://t.co/tMmwO7n494
-
This review comprehensively examines FXI inhibitors, delving into individual classes, evaluating the latest evidence from RCTs, and discussing future perspectives https://t.co/LvPdFIjg8K @AgewallStefan @FeliceGragnano @DFCapodanno @drgocchipinti @AGrecoMD #EHJPharmacotherapy https://t.co/UNMhqyabyh